Literature DB >> 18690112

Chronic unpredictable stress enhances cocaine-conditioned place preference in type 1 cannabinoid receptor knockout mice.

Laurence L Miller1, Sara J Ward, Linda A Dykstra.   

Abstract

Cannabinoid signaling via the type 1 cannabinoid (CB1) receptor modulates the effects of drugs of abuse and the response to exposure to stressors. In addition, exposure to stressors can alter the effects of drugs of abuse. This study examined the effects of exposure to chronic unpredictable stress (CUS) in CB1 receptor knockout (CB1 KO) mice and their wild-type (WT) littermates, using cocaine-conditioned place preference (CPP) to compare their response to cocaine. Mice were untreated or exposed to 2 weeks of CUS. After this period, the acquisition of a cocaine CPP was examined with one of three doses (3.2, 10.0, or 17.0 mg/kg) of cocaine. Untreated CB1 KO and WT mice both acquired the cocaine CPP; however, exposure to CUS enhanced the acquisition of the cocaine CPP in CB1 KO mice, but did not significantly alter the effects of cocaine in WT mice. Taken together, these findings support earlier evidence suggesting a role for the CB1 receptor in the response to stress as well as in the effects of cocaine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690112      PMCID: PMC3175354          DOI: 10.1097/FBP.0b013e32830ded11

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  66 in total

1.  The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.

Authors:  J Haller; N Bakos; M Szirmay; C Ledent; T F Freund
Journal:  Eur J Neurosci       Date:  2002-10       Impact factor: 3.386

2.  CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents.

Authors:  J Haller; B Varga; C Ledent; T F Freund
Journal:  Behav Pharmacol       Date:  2004-07       Impact factor: 2.293

3.  Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

Authors:  Emmanuel Valjent; Jennifer M Mitchell; Marie-Jo Besson; Jocelyne Caboche; Rafael Maldonado
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats.

Authors:  F Chaperon; P Soubrié; A J Puech; M H Thiébot
Journal:  Psychopharmacology (Berl)       Date:  1998-02       Impact factor: 4.530

5.  Requirement of cannabinoid receptor type 1 for the basal modulation of hypothalamic-pituitary-adrenal axis function.

Authors:  Daniela Cota; Michel-Alexander Steiner; Giovanni Marsicano; Cristina Cervino; James P Herman; Yvonne Grübler; Johanna Stalla; Renato Pasquali; Beat Lutz; Günter K Stalla; Uberto Pagotto
Journal:  Endocrinology       Date:  2006-12-28       Impact factor: 4.736

6.  Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress.

Authors:  M Papp; R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

7.  Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.

Authors:  P J Little; D R Compton; M R Johnson; L S Melvin; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1988-12       Impact factor: 4.030

8.  Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.

Authors:  M Navarro; E Hernández; R M Muñoz; I del Arco; M A Villanúa; M R Carrera; F Rodríguez de Fonseca
Journal:  Neuroreport       Date:  1997-01-20       Impact factor: 1.837

9.  Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats.

Authors:  Zheng-Xiong Xi; Krista Spiller; Arlene C Pak; Jeremy Gilbert; Christopher Dillon; Xia Li; Xiao-Qing Peng; Eliot L Gardner
Journal:  Neuropsychopharmacology       Date:  2007-08-29       Impact factor: 7.853

10.  Estrogen recruits the endocannabinoid system to modulate emotionality.

Authors:  Matthew N Hill; Eda S Karacabeyli; Boris B Gorzalka
Journal:  Psychoneuroendocrinology       Date:  2007-03-27       Impact factor: 4.905

View more
  8 in total

1.  Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.

Authors:  Ana Canseco-Alba; Norman Schanz; Branden Sanabria; Juan Zhao; Zhicheng Lin; Qing-Rong Liu; Emmanuel S Onaivi
Journal:  Behav Brain Res       Date:  2018-11-30       Impact factor: 3.332

2.  Decreased cocaine motor sensitization and self-administration in mice overexpressing cannabinoid CB₂ receptors.

Authors:  Auxiliadora Aracil-Fernández; José M Trigo; María S García-Gutiérrez; Antonio Ortega-Álvaro; Alexander Ternianov; Daniela Navarro; Patricia Robledo; Pere Berbel; Rafael Maldonado; Jorge Manzanares
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

3.  Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice.

Authors:  Xia Li; Alexander F Hoffman; Xiao-Qing Peng; Carl R Lupica; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Psychopharmacology (Berl)       Date:  2008-12-20       Impact factor: 4.530

4.  Beta-caryophyllene inhibits cocaine  addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder.

Authors:  Ewa Galaj; Guo-Hua Bi; Allamar Moore; Kai Chen; Yi He; Eliot Gardner; Zheng-Xiong Xi
Journal:  Neuropsychopharmacology       Date:  2020-10-17       Impact factor: 7.853

Review 5.  Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?

Authors:  Kari A Johnson; David M Lovinger
Journal:  Front Cell Neurosci       Date:  2016-11-11       Impact factor: 5.505

6.  Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats.

Authors:  Foteini Delis; Alexia Polissidis; Nafsika Poulia; Zuzana Justinova; George G Nomikos; Steven R Goldberg; Katerina Antoniou
Journal:  Int J Neuropsychopharmacol       Date:  2017-03-01       Impact factor: 5.176

Review 7.  Modulation of the endocannabinoid system: vulnerability factor and new treatment target for stimulant addiction.

Authors:  Stéphanie Olière; Antoine Joliette-Riopel; Stéphane Potvin; Didier Jutras-Aswad
Journal:  Front Psychiatry       Date:  2013-09-23       Impact factor: 4.157

8.  Transglutaminase 2 overexpression induces depressive-like behavior and impaired TrkB signaling in mice.

Authors:  C D Pandya; N Hoda; A Crider; D Peter; A Kutiyanawalla; S Kumar; A O Ahmed; G Turecki; C M Hernandez; A V Terry; A Pillai
Journal:  Mol Psychiatry       Date:  2016-09-13       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.